invest1 distinct publisher
A pancreatic pill proves pan-RAS is druggable. Lung and colon will price the claim
Rasonque roughly doubled median survival against a 6.7-month chemotherapy arm in a cancer where nearly every tumor carries a KRAS mutation. Neither condition repeats in the bigger indications.
Publishers:fortune.com
Reality
- Evidence60
- Adoption52
- Hype gap+27
- Incentives74